PROTAC EGFR degrader 2 [3031336-58-7]
Cat# HY-144304-25mg
Size : 25mg
Brand : MedChemExpress
Description |
PROTAC EGFR degrader 2 is a potent PROTAC EGFR degrader. PROTAC EGFR degrader 2 exhibits excellent antiproliferative activity with IC50 of 4.0 nM and good EGFR degradation activity with DC50 of 36.51 nM. PROTAC EGFR degrader 2 can be used for the synthesis of nitroreductase (NTR)-responsive PROTAC[1]. |
||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target[1] |
|
||||||||||||||||||||
Cellular Effect |
|
||||||||||||||||||||
Molecular Weight |
1151.78 |
||||||||||||||||||||
Formula |
C58H72ClFN12O8S |
||||||||||||||||||||
CAS No. | |||||||||||||||||||||
Appearance |
Solid |
||||||||||||||||||||
Color |
Light yellow to yellow |
||||||||||||||||||||
SMILES |
FC(C=CC(NC1=NC=NC2=CC(OCCCCCC3=CN(N=N3)CCOCCOCC(N[C@H](C(N4C[C@@H](C[C@H]4C(NCC5=CC=C(C=C5)C6=C(N=CS6)C)=O)O)=O)C(C)(C)C)=O)=C(C=C21)NC(/C=C/CN7CCCCC7)=O)=C8)=C8Cl |
||||||||||||||||||||
Shipping | Room temperature in continental US; may vary elsewhere. |
||||||||||||||||||||
Storage |
4°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen) |
||||||||||||||||||||
Solvent & Solubility |
In Vitro:
DMSO : 100 mg/mL (86.82 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles. Select the appropriate dissolution method based on your experimental animal and administration route.
For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
|
||||||||||||||||||||
Purity & Documentation | |||||||||||||||||||||
References |